Home
/ ZAI Lab
/ Competitors

ZAI Lab Competitors and Similar CompaniesClear all

ZAI Lab's competitors and similar companies include Amoy Diagnostics and Shanghai Junshi Biosciences.

	ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.	Amoy Diagnostics Amoy Diagnostics (AmoyDx, 厦门艾德生物医药科技股份有限公司) is a company that provides molecular diagnostic products and services for oncology precision medicine.	Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Founding Date	Founding Date 2014	Founding Date 2008	Founding Date 2012
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development medical devices oncology pharma therapy	Tags Healthcare biotech clinical research medical diagnostics oncology	Tags Healthcare biotech drug development oncology pharma
Locations	Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US	Locations Xiamen, CN HQ Singapore, SG	Locations Shanghai, CN HQ
Employees	Employees 1,869	Employees 1,144	Employees 2,578
Valuation ($)	Valuation ($) 3.2 b	Valuation ($) 1.3 b	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $460.2m (FY, 2025)	Revenue (est.) ¥1.2b (FY, 2025)	Revenue (est.) ¥2.4b (FY, 2025)
Cost of goods	Cost of goods $190.5m (FY, 2025)	Cost of goods ¥208.5m (FY, 2025)	Cost of goods ¥466.5m (FY, 2025)
Gross profit	Gross profit $269.6m (FY, 2025)	Gross profit ¥976m (FY, 2025)	Gross profit ¥2b (FY, 2025)
Net income	Net income ($175.5m) (FY, 2025)	Net income ¥361.3m (FY, 2025)	Net income (¥1b) (FY, 2025)